Titre : Abcès épidural

Abcès épidural : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Abcès épidural : Questions médicales les plus fréquentes", "headline": "Abcès épidural : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Abcès épidural : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Abcès épidural" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infections des espaces méningés", "url": "https://questionsmedicales.fr/mesh/D020819", "about": { "@type": "MedicalCondition", "name": "Infections des espaces méningés", "code": { "@type": "MedicalCode", "code": "D020819", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.228.709" } } }, "about": { "@type": "MedicalCondition", "name": "Abcès épidural", "alternateName": "Epidural Abscess", "code": { "@type": "MedicalCode", "code": "D020802", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Joseph H Schwab", "url": "https://questionsmedicales.fr/author/Joseph%20H%20Schwab", "affiliation": { "@type": "Organization", "name": "From the Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA (Dr. Schwab), and the Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA (Dr. Shah)." } }, { "@type": "Person", "name": "Akash A Shah", "url": "https://questionsmedicales.fr/author/Akash%20A%20Shah", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Sandra B Nelson", "url": "https://questionsmedicales.fr/author/Sandra%20B%20Nelson", "affiliation": { "@type": "Organization", "name": "Department of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, USA, 02114." } }, { "@type": "Person", "name": "Aditya V Karhade", "url": "https://questionsmedicales.fr/author/Aditya%20V%20Karhade", "affiliation": { "@type": "Organization", "name": "Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA, 02114, USA; Harvard Combined Orthopaedic Residency Program, 55 Fruit Street, Boston, MA, USA, 02114." } }, { "@type": "Person", "name": "Joseph F Baker", "url": "https://questionsmedicales.fr/author/Joseph%20F%20Baker", "affiliation": { "@type": "Organization", "name": "University of Auckland, Auckland, Auckland, New Zealand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36599813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ejh.13925" } }, { "@type": "ScholarlyArticle", "name": "Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36454598", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13387" } }, { "@type": "ScholarlyArticle", "name": "The safety of ABO minor incompatible platelets transfusions using a rapid infuser.", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38299721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17739" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36758527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000529542" } }, { "@type": "ScholarlyArticle", "name": "Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36369934", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17184" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002493" }, { "@type": "ListItem", "position": 4, "name": "Infections du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002494" }, { "@type": "ListItem", "position": 5, "name": "Infections des espaces méningés", "item": "https://questionsmedicales.fr/mesh/D020819" }, { "@type": "ListItem", "position": 6, "name": "Abcès épidural", "item": "https://questionsmedicales.fr/mesh/D020802" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Abcès épidural - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Abcès épidural", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Abcès épidural", "description": "Comment diagnostique-t-on un abcès épidural ?\nQuels tests sanguins sont utiles ?\nQuels symptômes indiquent un abcès épidural ?\nL'IRM est-elle toujours nécessaire ?\nPeut-on diagnostiquer sans imagerie ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Platelet+Transfusion&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Abcès épidural", "description": "Quels sont les symptômes principaux ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes neurologiques ?\nComment la douleur se manifeste-t-elle ?\nPeut-on avoir des symptômes sans fièvre ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Platelet+Transfusion&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Abcès épidural", "description": "Comment prévenir un abcès épidural ?\nLes patients à risque doivent-ils être surveillés ?\nLes soins post-opératoires sont-ils importants ?\nLes vaccinations aident-elles à prévenir ?\nFaut-il éviter certaines activités ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Platelet+Transfusion&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Abcès épidural", "description": "Quel est le traitement principal ?\nLes antibiotiques sont-ils toujours nécessaires ?\nQuand faut-il envisager une intervention chirurgicale ?\nY a-t-il des traitements non chirurgicaux ?\nCombien de temps dure le traitement ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Platelet+Transfusion&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Abcès épidural", "description": "Quelles sont les complications possibles ?\nPeut-on avoir des séquelles après traitement ?\nComment la septicémie se développe-t-elle ?\nLes complications sont-elles fréquentes ?\nY a-t-il un risque de récidive ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Platelet+Transfusion&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Abcès épidural", "description": "Quels sont les principaux facteurs de risque ?\nLes diabétiques sont-ils plus à risque ?\nLe tabagisme influence-t-il le risque ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes antécédents d'abcès augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Platelet+Transfusion&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un abcès épidural ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par IRM ou scanner, en plus des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire peuvent montrer une élévation des globules blancs et des marqueurs inflammatoires." } }, { "@type": "Question", "name": "Quels symptômes indiquent un abcès épidural ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs dorsales, fièvre, faiblesse, et parfois des troubles neurologiques." } }, { "@type": "Question", "name": "L'IRM est-elle toujours nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM est souvent recommandée, mais un scanner peut suffire dans certains cas." } }, { "@type": "Question", "name": "Peut-on diagnostiquer sans imagerie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic préliminaire peut être fait cliniquement, mais l'imagerie est cruciale." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur intense, fièvre, et parfois des troubles moteurs." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus subtils chez les personnes âgées." } }, { "@type": "Question", "name": "Y a-t-il des signes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes comme la faiblesse ou des engourdissements peuvent apparaître." } }, { "@type": "Question", "name": "Comment la douleur se manifeste-t-elle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La douleur est souvent localisée dans le dos et peut irradier vers les membres." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans fièvre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent ne pas présenter de fièvre malgré un abcès." } }, { "@type": "Question", "name": "Comment prévenir un abcès épidural ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et traiter rapidement les infections cutanées." } }, { "@type": "Question", "name": "Les patients à risque doivent-ils être surveillés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients immunodéprimés ou ayant des antécédents d'infections doivent être surveillés." } }, { "@type": "Question", "name": "Les soins post-opératoires sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins appropriés après une chirurgie peuvent prévenir les infections." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent réduire le risque d'infections, mais pas spécifiquement d'abcès." } }, { "@type": "Question", "name": "Faut-il éviter certaines activités ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les activités à risque qui pourraient entraîner des infections est conseillé." } }, { "@type": "Question", "name": "Quel est le traitement principal ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la chirurgie pour drainer l'abcès, souvent suivi d'antibiotiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antibiotiques sont essentiels pour traiter l'infection sous-jacente." } }, { "@type": "Question", "name": "Quand faut-il envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale est nécessaire si l'abcès provoque des symptômes neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements non chirurgicaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, un traitement médical peut être suffisant, mais c'est rare." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement dépend de la gravité, mais peut durer plusieurs semaines." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions nerveuses, une septicémie, et des douleurs chroniques." } }, { "@type": "Question", "name": "Peut-on avoir des séquelles après traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles comme des douleurs chroniques ou des déficits neurologiques peuvent survenir." } }, { "@type": "Question", "name": "Comment la septicémie se développe-t-elle ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La septicémie peut se développer si l'infection se propage dans le sang, nécessitant une attention urgente." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent être graves, surtout si le traitement est retardé." } }, { "@type": "Question", "name": "Y a-t-il un risque de récidive ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de récidive existe, surtout si les facteurs de risque ne sont pas gérés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, les infections cutanées, et les antécédents chirurgicaux." } }, { "@type": "Question", "name": "Les diabétiques sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients diabétiques ont un risque accru d'infections et d'abcès épiduraux." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affaiblir le système immunitaire et augmenter le risque d'infections." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les antécédents d'abcès augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents d'abcès épiduraux augmente le risque de récidive." } } ] } ] }

Sources (7078 au total)

Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.

Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based... A systematic literature search was conducted in seven databases for SRs on effectiveness (including dose and timing, transfusion trigger and ratio to other blood products), production modalities and d... We identified 110 SRs. The majority focused on clinical effectiveness, including prophylactic or therapeutic transfusions compared to no platelet transfusion (34 SRs), prophylactic compared to therape... An interactive evidence map of SRs and evidence-based guidelines in the field of platelet transfusion has been developed and identified multiple reviews. This work serves as a tool for researchers loo...

The safety of ABO minor incompatible platelets transfusions using a rapid infuser.

Administering platelets through a rapid infuser is proven to be safe. However, the clinical significance of infusing ABO-incompatible platelets with red blood cells (RBCs) in a rapid infuser remains u... Seven in vitro studies were performed including five cases (type A RBCs and type O platelets) and two controls (type A RBCs and platelets). Anti-A titers were measured in platelet units. An RBC unit a... The post-mix DAT was positive for IgG in all test samples (5/5), and weakly positive for complement in 3/5. The changes in free Hb in test cases between measured and calculated post-mix spanned -2.2 t... Our study suggested that mixing ABO-incompatible platelets with RBCs in a rapid infuser does not induce in vitro hemolysis. These findings support the use of rapid infusers regardless of platelet comp...

Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.

The aims of this study were to observe the therapeutic effect of platelet (PLT) transfusion and to analyze influencing factors for the sake of providing useful clues for improving the efficacy of PLT ... Included in this study were patients who received PLT transfusion in the affiliated hospital of Nantong University. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count be... A total of 364 patients received 1,060 PLT transfusions, including 728 successful transfusions and 332 unsuccessful transfusions. When the patients were grouped according to different etiologies, sign... To reduce PTR, multiple factors should be considered comprehensively when PLT transfusion therapy is to be implemented in clinical practice. PLT antibody is the main immune factor causing PTR....

Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.

Following the results of the PlaNeT-2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 10... Prospective observational cohort chart-review study comparing all neonates consecutively admitted to the NICU during two 5-months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible... Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet-transfused versus 9.2% in 2013 (p = .027). Platelet trans... Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet-transfused neonates by 46% and reduced donor exposure in transfused patients....

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia... Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group.... 43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland.... 660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10... Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10... Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 yea... Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as c... Infants randomised to a higher platelet transfusion threshold of 50×10... ISRCTN87736839....

Aged versus fresh autologous platelet transfusion in a two-hit healthy volunteer model of transfusion-related acute lung injury.

Transfusion-related acute lung injury (TRALI) is a severe complication of blood transfusion that is thought of as a two-hit event: first the underlying patient condition (e.g., sepsis), and then the t... In a randomized controlled trial, 18 healthy male volunteers received a first hit of experimental endotoxemia (2 ng/kg lipopolysaccharide), and a second hit of fresh (2-day old) or aged (7-day old) au... All subjects reacted adequately to lipopolysaccharide infusion and satisfied SIRS criteria (increased pulse [>90/min] and temperature [>38°C]). There were no differences between the saline, fresh, and... In a human endotoxemia model of autologous platelet transfusion, with an adequate first hit and platelet storage lesion, transfusion of 7-day-old PC does not increase pulmonary inflammation compared w...

A randomized cross-over study of cryopreserved platelets in prophylactic transfusions of thrombocytopenic patients.

The short shelf-life of liquid-stored platelets (LP) at 20-24°C poses shortage and wastage challenges. Cryopreserved platelets have significantly extended shelf-life, and were safe and efficacious for... We performed a phase 1b/2a randomized cross-over study comparing the safety and efficacy of cryopreserved buffy coat-derived pooled platelets (CP) to LP in the prophylactic transfusions of thrombocyto... A total of 18 adults were randomly assigned 1:1 to CP and LP for their first thrombocytopenic period (TP) of up to 28-days. A total of 14 crossed over to the other platelet-arm for the second TP. Over... During shortages, CP may supplement LP in prophylactic transfusions of thrombocytopenic patients....